TwinKnowledge | $3,700,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
SchoolAI | $25,000,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Cambrian Network | $5,900,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)
